Hypoxia inducible factor-prolyl hydroxylase inhibitors in anemic patients with non-dialysis dependent chronic kidney disease: a meta-analysis of randomized clinical trials.
Mohamed Maali Gumaa MohamedMosunmoluwa OyenugaSafia ShaikhAbayomi OyenugaBabikir KheiriChristian NwankwoPublished in: International urology and nephrology (2022)
HIF-PHI might represent a safe, and convenient alternative to ESA in non-dialysis dependent CKD patients with anemia.